Leaflet ALSEMORA 20mg film-coated tablets

Product code:
W71893001
Quantity:
28
Indicated for:
Alzheimer's disease; dementia
Route of administration:
oral
Substance:
memantine (NMDA receptor antagonist)
ATC
N06DX01 — Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Memantine is a medication used to treat moderate to severe dementia associated with Alzheimer’s disease. It works by blocking NMDA (N-methyl-D-aspartate) receptors in the brain, reducing the excessive effects of glutamate, a neurotransmitter that, in high amounts, can contribute to nerve cell damage.

Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.

Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.

General data about ALSEMORA 20mg

Substance:
memantine
Date of latest medicines list:
01-06-2026
Product code:
W71893001
Concentration:
20mg
Pharmaceutical form:
film-coated tablets
Quantity:
28
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
AS GRINDEKS - LETONIA
Holder:
AS GRINDEKS - LETONIA
Number:
16577/2026/01
Shelf life:
3 years

Concentrations available for memantine

  • 10mg
  • 10mg/g
  • 10mg/ml
  • 15mg
  • 20mg
  • 5mg
  • 5mg/10mg/15mg/20mg
  • 5mg/dose
  • 5mg/dose eliberata